Biotech/Medical Tech Stock News from Investorideas.com

Biotech, Pharma and Medical Technology Stock News : OTC stocks, TSX Stocks, NASDAQ and NYSE

Monday, August 8, 2011

Mr. Stephen M. Simes, President and CEO of BioSante Pharmaceuticals (NASDAQ: BPAX), Discusses the Future of LibiGel® Following Closing of $48 Million Offering

›
Point Roberts, WA, LINCOLNSHIRE, Ill - August 8, 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research portal co...
Wednesday, August 3, 2011

Biotech and Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Closes $48.0 Million Public Offering of Common Stock

›
LINCOLNSHIRE, Ill. - August 3, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. ( NASDAQ:BPAX ) today announced the closi...
Thursday, July 28, 2011

Biotech Stock Trading News; (OTCBB:AEMD), (NASDAQ:QCOR) , (NASDAQ:MSHL), (NASDAQ:GILD)

›
Point Roberts, WA - July 28, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and p...

Biotech and Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Prices Public Offering of Common Stock

›
LINCOLNSHIRE, Ill. - July 28, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. ( NASDAQ:BPAX ) today announced the pricin...
Tuesday, July 26, 2011

Biotech and Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Reports Second Quarter 2011 Financial Results

›
LINCOLNSHIRE, Ill. - July 26, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. ( NASDAQ:BPAX ) today announced its financi...
Friday, July 22, 2011

Biotech/Pharma Trading Alert for BioSante (NASDAQ: BPAX)

›
Point Roberts, WA, LINCOLNSHIRE, Ill - July 22, 2011 - Investorideas.com, a leader in sector stock research for independent investors , is...
Thursday, July 21, 2011

Pharma and Biotech News; BioSante Pharmaceuticals (NASDAQ: BPAX) Signs Melanoma Vaccine License

›
LINCOLNSHIRE, Ill. - July 21, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. ( NASDAQ:BPAX ) today announced an exclusi...
‹
›
Home
View web version
Powered by Blogger.